Association between the SKAP1 gene rs2084881 polymorphism and BABAM1 gene rs8170 polymorphism in ovarian cancer susceptibility

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 544

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

IPMCMED03_056

تاریخ نمایه سازی: 6 خرداد 1398

Abstract:

Introduction: Ovarian cancer is one of the most common cancers in women that due to the absence of obvious clinical symptoms in the early stages of the disease, the mortality rate of this cancer is increasing. Given the importance of early diagnosis in the treatment of ovarian cancer, Finding biomarkers associated with this disease is essential. According to studies conducted in other countries, rs2084881 on the SKAP1 gene and rs8170 on the BABAM1 gene are risk factors for ovarian cancer. Our main goal in this study is to examine these two genes in Iranian populations in order to obtain biomarkers for the prognosis of the risk of ovarian cancer.Methods: 100 peripheral blood samples were collected from 100 controls and 50 patients and after extraction of DNA with Tetra-ARMS PCR, the genes SKAP1 and BABAM1 were studied. The tetra ARMS-PCR method is a valuable method because it has a simpler analysis, in addition to its high speed and low cost.Results: SKAP1 and BABAM1 genes were observed heterozygote in control samples. Checking on patient samples is ongoing, but most of them are expected to have similar results with controls. Contrary to previous studies, therefore, there is no significant relationship between these genes and ovarian cancer.Conclusion: SKAP1 and BABAM1 genes can’t be used as potential biomarkers for ovarian cancer in Iranian populations. These findings lead us to find suitable biomarkers for the population with respect to personalized medicine, should be made an appropriate treatment according to the individual genotype.

Authors

Faeze Ghasemi

National Institute of Genetic Engineering and Biotechnology,M.S.c

Farzaneh Sabouni

Department of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology

Fatemeh Shahi

National Institute of Genetic Engineering and Biotechnology,M.S.c

Bahareh Abbasi

Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology